SOURCE: Novo Nordisk A/S

December 22, 2010 18:08 ET

Degludec Significantly Reduces Risk of Hypoglycaemia During the Night Compared to Insulin Glargine in Two Long-Term Studies

BAGSVAERD, DENMARK--(Marketwire - December 22, 2010) -

Company Announcement no 71 2010:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.


Contact Information